Ionis Pharmaceuticals, Inc. Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security
Ionis Pharmaceuticals, Inc. (IONS) reported Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security of $12.50 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities · last filed 2020-03-02
- Ionis Pharmaceuticals, Inc. repayment of long-term debt, long-term lease obligation, and capital security for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- Ionis Pharmaceuticals, Inc. repayment of long-term debt, long-term lease obligation, and capital security for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- Ionis Pharmaceuticals, Inc. repayment of long-term debt, long-term lease obligation, and capital security for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- Ionis Pharmaceuticals, Inc. repayment of long-term debt, long-term lease obligation, and capital security for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- Ionis Pharmaceuticals, Inc. repayment of long-term debt, long-term lease obligation, and capital security for fiscal 2019 was $12.50M.
- Ionis Pharmaceuticals, Inc. repayment of long-term debt, long-term lease obligation, and capital security for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- Ionis Pharmaceuticals, Inc. repayment of long-term debt, long-term lease obligation, and capital security for fiscal 2017 was $3.60M, a 49.07% decline from fiscal 2016.
- Ionis Pharmaceuticals, Inc. repayment of long-term debt, long-term lease obligation, and capital security for fiscal 2016 was $7.07M, a 21.99% decline from fiscal 2015.
| Period end | Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security 3 month | Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security 6 month | Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security 9 month | Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security 12 month |
|---|---|---|---|---|
| 2019-12-31 | $12.50M 10-K · filed 2020-03-02 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $0.00 derived: sum of 2 quarters · filed 2020-03-02 | $0.00 derived: sum of 3 quarters · filed 2020-03-02 | $0.00 10-K · filed 2020-03-02 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $0.00 derived: sum of 2 quarters · filed 2018-11-06 | $0.00 10-Q · filed 2018-11-06 | $22.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $0.00 10-Q · filed 2018-08-07 | $22.00K derived: sum of 3 quarters · filed 2020-03-02 | $321.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-07 | $22.00K derived: sum of 2 quarters · filed 2020-03-02 | $321.00K derived: sum of 3 quarters · filed 2020-03-02 | $1.96M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $321.00K derived: sum of 2 quarters · filed 2020-03-02 | $1.96M derived: sum of 3 quarters · filed 2020-03-02 | $3.60M 10-K · filed 2020-03-02 |
| 2017-09-30 | $299.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $1.94M derived: sum of 2 quarters · filed 2018-11-06 | $3.58M 10-Q · filed 2018-11-06 | $5.21M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $3.28M 10-Q · filed 2018-08-07 | $4.92M derived: sum of 3 quarters · filed 2019-03-01 | $6.63M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $1.64M 10-Q · filed 2018-05-07 | $3.28M derived: sum of 2 quarters · filed 2019-03-01 | $4.99M derived: sum of 3 quarters · filed 2019-03-01 | $6.85M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $3.35M derived: sum of 2 quarters · filed 2019-03-01 | $5.21M derived: sum of 3 quarters · filed 2019-03-01 | $7.07M 10-K · filed 2019-03-01 |
| 2016-09-30 | $1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $3.57M derived: sum of 2 quarters · filed 2017-11-07 | $5.43M 10-Q · filed 2017-11-07 | $7.22M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $3.72M 10-Q · filed 2017-08-09 | $5.51M derived: sum of 3 quarters · filed 2018-02-28 | $7.58M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $1.86M 10-Q · filed 2017-05-09 | $3.65M derived: sum of 2 quarters · filed 2018-02-28 | $5.72M derived: sum of 3 quarters · filed 2018-02-28 | $8.32M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $3.87M derived: sum of 2 quarters · filed 2018-02-28 | $6.47M derived: sum of 3 quarters · filed 2018-02-28 | $9.06M 10-K · filed 2018-02-28 |
| 2015-09-30 | $2.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $4.67M derived: sum of 2 quarters · filed 2016-11-09 | $7.26M 10-Q · filed 2016-11-09 | $9.85M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $5.19M 10-Q · filed 2016-08-09 | $7.77M derived: sum of 3 quarters · filed 2017-03-01 | $10.38M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $2.59M 10-Q · filed 2016-05-05 | $5.17M derived: sum of 2 quarters · filed 2017-03-01 | $7.79M derived: sum of 3 quarters · filed 2017-03-01 | $10.49M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $5.20M derived: sum of 2 quarters · filed 2017-03-01 | $7.90M derived: sum of 3 quarters · filed 2017-03-01 | $10.59M 10-K · filed 2017-03-01 |
| 2014-09-30 | $2.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $5.31M derived: sum of 2 quarters · filed 2015-11-09 | $8.00M 10-Q · filed 2015-11-09 | $10.74M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $5.39M 10-Q · filed 2015-08-05 | $8.13M derived: sum of 3 quarters · filed 2016-02-26 | $10.86M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $2.69M 10-Q · filed 2015-05-05 | $5.42M derived: sum of 2 quarters · filed 2016-02-26 | $8.16M derived: sum of 3 quarters · filed 2016-02-26 | $10.96M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $5.47M derived: sum of 2 quarters · filed 2016-02-26 | $8.27M derived: sum of 3 quarters · filed 2016-02-26 | $11.04M 10-K · filed 2016-02-26 |
| 2013-09-30 | $2.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $5.53M derived: sum of 2 quarters · filed 2014-11-07 | $8.31M 10-Q · filed 2014-11-07 | $11.15M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $5.57M 10-Q · filed 2014-08-04 | $8.41M derived: sum of 3 quarters · filed 2015-03-02 | $11.16M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $2.77M 10-Q · filed 2014-05-06 | $5.61M derived: sum of 2 quarters · filed 2015-03-02 | $8.36M derived: sum of 3 quarters · filed 2015-03-02 | $10.70M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $5.59M derived: sum of 2 quarters · filed 2015-03-02 | $7.93M derived: sum of 3 quarters · filed 2015-03-02 | $10.42M 10-K · filed 2015-03-02 |
| 2012-09-30 | $2.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $5.09M derived: sum of 2 quarters · filed 2013-11-05 | $7.58M 10-Q · filed 2013-11-05 | $9.01M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | $2.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $4.83M 10-Q · filed 2013-08-06 | $6.26M derived: sum of 3 quarters · filed 2014-03-03 | $7.83M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $2.49M 10-Q · filed 2013-05-07 | $3.92M derived: sum of 2 quarters · filed 2014-03-03 | $5.49M derived: sum of 3 quarters · filed 2014-03-03 | $6.94M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $2.99M derived: sum of 2 quarters · filed 2014-03-03 | $4.45M derived: sum of 3 quarters · filed 2014-03-03 | $5.86M 10-K · filed 2014-03-03 |
| 2011-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $3.02M derived: sum of 2 quarters · filed 2012-11-06 | $4.44M 10-Q · filed 2012-11-06 | $5.69M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $2.87M 10-Q · filed 2012-08-06 | $4.13M derived: sum of 3 quarters · filed 2013-02-28 | $5.28M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | $1.41M 10-Q · filed 2012-05-09 | $2.67M derived: sum of 2 quarters · filed 2013-02-28 | $3.82M derived: sum of 3 quarters · filed 2013-02-28 | $4.80M derived: sum of 4 quarters · filed 2013-02-28 |
| 2010-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $2.41M derived: sum of 2 quarters · filed 2013-02-28 | $3.39M derived: sum of 3 quarters · filed 2013-02-28 | $4.35M 10-K · filed 2013-02-28 |
| 2010-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $2.13M derived: sum of 2 quarters · filed 2011-11-08 | $3.10M 10-Q · filed 2011-11-08 | $4.03M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-06-30 | $980.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $1.94M 10-Q · filed 2011-08-08 | $2.87M derived: sum of 3 quarters · filed 2012-02-29 | $3.60M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-03-31 | $963.00K 10-Q · filed 2011-05-06 | $1.89M derived: sum of 2 quarters · filed 2012-02-29 | $2.62M derived: sum of 3 quarters · filed 2012-02-29 | |
| 2009-12-31 | $931.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $1.66M derived: sum of 2 quarters · filed 2012-02-29 | $2.83M 10-K · filed 2012-02-29 | |
| 2009-09-30 | $730.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $1.90M 10-Q · filed 2010-11-05 | ||
| 2009-06-30 | $1.17M 10-Q · filed 2010-08-09 | |||
| 2008-12-31 | $7.24M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |